Question 1

How many shares of ALXN does BALYASNY ASSET MANAGEMENT L.P. own?

Accepted Answer

BALYASNY ASSET MANAGEMENT L.P. previously held 0 shares of ALXN (ALEXION PHARMACEUTICALS INC) before exiting the position in 2021-Q3.

Question 2

What is BALYASNY ASSET MANAGEMENT L.P.'s ALXN position worth?

Accepted Answer

BALYASNY ASSET MANAGEMENT L.P.'s ALXN position was last reported at $0 in 2021-Q3 before the exit.

Question 3

Is BALYASNY ASSET MANAGEMENT L.P. buying or selling ALXN?

Accepted Answer

In 2021-Q3, BALYASNY ASSET MANAGEMENT L.P. exited their ALXN position entirely (-100.0% change in shares).

Question 4

When did BALYASNY ASSET MANAGEMENT L.P. first buy ALXN?

Accepted Answer

Based on available 13F filings, BALYASNY ASSET MANAGEMENT L.P. first reported a position in ALXN in 2018-Q4. They have held the position across 12 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q2	Decreased	771,620	-3.6%	$141.8M	0.7%	—	0
2021-Q1	Increased	800,344	+142.7%	$122.4M	0.6%	—	68
2020-Q4	Increased	329,802	+4.4%	$51.5M	0.3%	—	37
2020-Q3	Increased	316,028	+115.7%	$36.2M	0.3%	—	56
2020-Q2	Increased	146,522	+52.3%	$16.4M	0.1%	—	47
2020-Q1	Decreased	96,219	-69.6%	$8.6M	0.1%	—	0
2019-Q4	Increased	316,499	+135x	$34.2M	0.2%	—	56
2019-Q3	Decreased	2,330	-94.9%	$228,000	0.0%	—	0
2019-Q2	Decreased	45,677	-64.5%	$6M	0.0%	—	0
2019-Q1	Decreased	128,598	-66.6%	$17.4M	0.1%	—	0
2018-Q4	New	384,945	-	$37.5M	0.3%	—	48

ALXN12 quarters

ALXN
12 quarters